Advancements in Defining, Diagnosing and Staging MDS

In this episode of our podcast, we dive deep into the complexities of lower-risk myelodysplastic syndromes (MDS). Join our expert panel as they discuss the challenges of diagnosing MDS, the importance of ruling out reversible causes, and the role of cytogenetics and next-generation sequencing (NGS) in understanding this condition. Key Topics Covered: • What is lower-risk MDS and who is affected? • The historical context and evolution of MDS terminology • The significance of accurate diagnosis and initial workup • The role of bone marrow biopsies versus peripheral blood in testing • How to effectively risk stratify patients using the IPSS-M and IPSS-R scoring systems • The implications of genetic mutations on treatment and prognosis Whether you're a healthcare professional or someone looking to understand more about MDS, this episode provides valuable insights into the diagnosis, treatment options, and the future of managing this rare blood condition. Tune in for an informative discussion that could change the way you think about MDS! Website: https://oncupdates.com/ Mail: [email protected] X/twitter: https://x.com/OncUpdates Don't forget to like, subscribe, and hit the notification bell for more episodes! #MyelodysplasticSyndrome, #MDS, #IPSSR, #GeneticTesting, #Hematology